Ampio Pharmaceuticals, Inc. Quarterly Entity Common Stock, Shares Outstanding from Q2 2011 to Q1 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Ampio Pharmaceuticals, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2011 to Q1 2024.
  • Ampio Pharmaceuticals, Inc. Entity Common Stock, Shares Outstanding for the quarter ending March 15, 2024 was 1.14M shares, a 92.5% decline year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 1.14M -14M -92.5% Mar 15, 2024 10-K 2024-03-27
Q3 2023 832K -14.3M -94.5% Nov 10, 2023 10-Q 2023-11-14
Q2 2023 15.1M -211M -93.3% Aug 7, 2023 10-Q 2023-08-08
Q1 2023 15.1M -212M -93.4% Mar 22, 2023 10-K 2023-03-27
Q3 2022 15.1M -187M -92.5% Nov 11, 2022 10-Q 2022-11-14
Q2 2022 226M +25.8M +12.9% Aug 8, 2022 10-Q 2022-08-09
Q1 2022 227M +31.5M +16.1% Apr 20, 2022 10-K/A 2022-05-02
Q3 2021 202M +17.1M +9.23% Oct 29, 2021 10-Q 2021-11-10
Q2 2021 200M +23.9M +13.5% Jul 30, 2021 10-Q 2021-08-04
Q1 2021 196M +30.8M +18.7% Apr 26, 2021 10-Q 2021-05-05
Q3 2020 185M +26.4M +16.6% Oct 31, 2020 10-Q 2020-11-03
Q2 2020 177M +34.3M +24.1% Jul 31, 2020 10-Q 2020-07-31
Q1 2020 165M +53.7M +48.3% Apr 30, 2020 10-Q 2020-05-06
Q4 2019 159M Feb 14, 2020 10-K 2020-02-21
Q3 2019 159M +51.9M +48.7% Nov 1, 2019 10-Q 2019-11-07
Q2 2019 142M +35.7M +33.5% Aug 1, 2019 10-Q 2019-08-09
Q1 2019 111M +26.3M +31% Mar 1, 2019 10-K 2019-03-18
Q3 2018 107M +30.8M +40.5% Nov 12, 2018 10-Q 2018-11-14
Q2 2018 107M +38.3M +56.1% Aug 13, 2018 10-Q 2018-08-14
Q1 2018 84.8M +27.6M +48.2% Mar 1, 2018 10-K 2018-03-06
Q3 2017 75.9M +18.8M +32.8% Nov 2, 2017 10-Q 2017-11-07
Q2 2017 68.2M +16.2M +31.2% Aug 2, 2017 10-Q 2017-08-09
Q1 2017 57.2M +5.23M +10% Mar 1, 2017 10-K 2017-03-16
Q3 2016 57.2M +5.18M +9.97% Nov 1, 2016 10-Q 2016-11-08
Q2 2016 52M +18.1K +0.04% Aug 1, 2016 10-Q 2016-08-02
Q1 2016 52M +28.5K +0.06% May 1, 2016 10-Q 2016-05-06
Q4 2015 52M +44.2K +0.09% Feb 1, 2016 10-K 2016-02-26
Q3 2015 52M +26K +0.05% Nov 1, 2015 10-Q 2015-11-06
Q2 2015 52M +26K +0.05% Aug 1, 2015 10-Q 2015-08-07
Q1 2015 52M +71.7K +0.14% May 1, 2015 10-Q 2015-05-08
Q4 2014 52M +9.84M +23.3% Feb 1, 2015 10-K 2015-02-24
Q3 2014 52M +10.2M +24.4% Nov 1, 2014 10-Q 2014-11-07
Q2 2014 52M +14.9M +40.1% Aug 8, 2014 10-Q 2014-08-08
Q1 2014 51.9M +14.8M +40% May 7, 2014 10-Q 2014-05-07
Q4 2013 42.1M Feb 12, 2014 10-K 2014-02-14
Q3 2013 41.8M +4.78M +12.9% Nov 8, 2013 10-Q 2013-11-08
Q2 2013 37.1M +115K +0.31% Aug 9, 2013 10-Q 2013-08-09
Q1 2013 37.1M +5.92M +19% Mar 6, 2013 10-K 2013-03-06
Q3 2012 37M +8.2M +28.5% Nov 2, 2012 10-Q 2012-11-02
Q2 2012 37M +8.27M +28.8% Aug 3, 2012 10-Q 2012-08-03
Q1 2012 31.2M May 4, 2012 10-Q 2012-05-04
Q4 2011 31.1M Feb 9, 2012 10-K 2012-02-09
Q3 2011 28.8M Nov 1, 2011 10-Q 2011-11-01
Q2 2011 28.7M Aug 12, 2011 10-Q 2011-08-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.